VistaGen Therapeutics Signs New Lease in South SF
The biotech company applying human pluripotent stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening recently signed a new lease for 10,000 SF of research & development space at 333 Allerton Avenue. VistaGen agreed to pay rent starting in the mid-$2.40s with 3% bumps for the 5-year lease term.